Back

Effectiveness of bivalent RSV prefusion F protein-based vaccine in individuals with and without atrial fibrillation: a prespecified analysis of the DAN-RSV trial

28 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: prevention and modifiable risk factors Prevention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Caroline Espersen

Herlev-Gentofte University Hospital, Gentofte (Denmark)

4 More presentations in this session

Presentation thumbnail
Relation of healthy lifestyle to the genetic predisposition for atrial fibrillation: results from a national prospective cohort
Professor R. Zhang (Dalian, CN)
Presentation thumbnail
Association between systolic blood pressure time in target range and incident atrial fibrillation: a prospective cohort study in the UK Biobank
Professor H. Bao (Nanchang, CN)
Abstract Slides Video
Presentation thumbnail
Asymmetric risk score architecture in atrial fibrillation: renal impairment inflates bleeding but not thrombotic risk estimation
Miss M. Petridou (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
Non-linear associations between systolic blood pressure and clinical outcomes in atrial fibrillation and net clinical benefit of oral anticoagulants: a dose-response meta-analysis
Doctor E. Shahmohamadi (Adelaide, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: prevention and modifiable risk factors

The Event

Event poster

ESC Congress 2026

28 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
DAN-RSV: RSVpreF vaccine for preventing cardiorespiratory hospitalizations
30 August 2025
thumbnail
Congress Presentation
Glucagon-like peptide-1 receptor agonists reduce atrial fibrillation among patients with heart failure with preserved ejection fraction - A meta-analysis of randomised-controlled trials
29 August 2025
thumbnail
Congress Presentation
High-dose vs standard-dose influenza vaccine in older adults with atrial fibrillation, a prespecified analysis of the FLUNITY-HD study
28 August 2026
thumbnail
Congress Presentation
Atrial fibrillation and in-hospital mortality in Covid-19 patients
16 April 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources